- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00466804
Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients
Observational Study of Alloimmunity in Cardiac Transplant Recipients
Study Overview
Detailed Description
A major cause of heart transplant failure is the blockage of blood flow from lesions caused by ongoing injury and repair of the graft by the host's immune system. However, the role of T cells, antibodies, and other parts of the recipient's immune system are not well understood in transplant injury. Currently, there are no effective, noninvasive ways to detect or predict how an individual's immune system will react to a transplant. The purpose of this study is to correlate current noninvasive monitoring tests with long-term graft survival and function, and determine which tests are the most accurate predictors of this survival.
Participants in this study must currently be on the waiting list for a heart transplant and have a donor heart available to them. This study will consist of six study visits over 12 months. The baseline visit will occur on the day of transplantation. Follow-up visits will occur at Week 6 and Months 3, 6, 9, and 12 post-transplant. At each visit, a physical exam, medication tracking, assessment of graft survival, and blood and urine collection will occur. At the Week 6 and Month 12 visits, intravascular ultrasound and echocardiograms will occur. At the Week 6, Month 6, and Month 12 visits, endomyocardial biopsies will also occur. No immunosuppressive therapy will be provided by the study.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
California
-
San Francisco, California, United States, 94143
- University of California
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University Medical School
-
Maywood, Illinois, United States, 60153
- Loyola University School of Medicine
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- University of Maryland
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Brigham and Women's Hospital
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
New Jersey
-
Newark, New Jersey, United States, 07112
- Beth Israel Medical Center
-
-
New York
-
New York, New York, United States, 10029
- Mount Sinai School of Medicine
-
-
Ohio
-
Cleveland, Ohio, United States, 44122
- The Cleveland Clinic Foundation
-
-
Texas
-
Dallas, Texas, United States, 75230
- Medical City Dallas Hospital
-
-
Utah
-
Salt Lake City, Utah, United States, 84148
- University of Utah, LDS Hospital
-
Salt Lake City, Utah, United States, 84148
- University of Utah, VACM.LDS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age greater than 10 and a body mass of 30 kg (66 lbs) or more
- On waiting list for a heart transplant for whom a donor heart available
- Willing to comply with study protocol
- Willing to use acceptable forms of contraception
- Parent or guardian willing to provide consent, if applicable
Exclusion Criteria:
- Receiving multiple organ transplants
- Previously received organ transplants
- Other comorbidities that, in the opinion of the site investigator, would interfere with the study
- Currently taking immunosuppression for nontransplant reasons
- Participation in an interventional clinical trial
- Pregnancy or breastfeeding
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Heart Transplant Recipients
People who will have a heart transplant
|
People in this study will have a heart transplant and be monitored for signs of rejection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Composite Measure of Transplant Health
Time Frame: 12 months after enrollment in study
|
A composite of incidence of the following:
|
12 months after enrollment in study
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Jiang S, Lechler RI. CD4+CD25+ regulatory T-cell therapy for allergy, autoimmune disease and transplant rejection. Inflamm Allergy Drug Targets. 2006 Dec;5(4):239-42. doi: 10.2174/187152806779010981.
- Starling RC, Pham M, Valantine H, Miller L, Eisen H, Rodriguez ER, Taylor DO, Yamani MH, Kobashigawa J, McCurry K, Marboe C, Mehra MR, Zuckerman A, Deng MC; Working Group on Molecular Testing in Cardiac Transplantation. Molecular testing in the management of cardiac transplant recipients: initial clinical experience. J Heart Lung Transplant. 2006 Dec;25(12):1389-95. doi: 10.1016/j.healun.2006.10.002. No abstract available. Erratum In: J Heart Lung Transplant. 2007 Feb;26(2):204.
- Zheng XX, Sanchez-Fueyo A, Sho M, Domenig C, Sayegh MH, Strom TB. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity. 2003 Oct;19(4):503-14. doi: 10.1016/s1074-7613(03)00259-0.
- Starling RC, Stehlik J, Baran DA, Armstrong B, Stone JR, Ikle D, Morrison Y, Bridges ND, Putheti P, Strom TB, Bhasin M, Guleria I, Chandraker A, Sayegh M, Daly KP, Briscoe DM, Heeger PS; CTOT-05 consortium. Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study. Am J Transplant. 2016 Jan;16(1):121-36. doi: 10.1111/ajt.13422. Epub 2015 Aug 10.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- DAIT CTOT-05
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Transplant
-
University Health Network, TorontoNot yet recruitingSolid Organ Transplant | Liver Transplant | Kidney Transplant | Heart Transplant
-
National Institute of Allergy and Infectious Diseases...Clinical Trials in Organ TransplantationTerminatedHeart Transplantation | Heart Transplant | Primary Heart TransplantUnited States
-
University of MichiganHoffmann-La RocheCompletedKidney Transplant Recipient | Heart Transplant RecipientUnited States
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI)CompletedLung Transplant | Self-management | Heart TransplantUnited States
-
Juan Francisco Delgado JimenezFundación Centro Nacional de Investigaciones Cardiovasculares Carlos IIIActive, not recruitingAntibody-mediated Rejection | Heart Transplant Rejection | Transplant FailureSpain
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Duke University; St. Paul's Hospital... and other collaboratorsActive, not recruitingHeart Diseases | Heart Failure | Transplant; Failure, Heart | Heart Transplant Failure and Rejection | Heart Failure,Congestive | Transplant FailureCanada, United States
-
TransMedicsRecruiting
-
Fondazione Don Carlo Gnocchi OnlusRecruiting
-
Xie MingxingShanghai Zhongshan Hospital; Second Affiliated Hospital, School of Medicine... and other collaboratorsNot yet recruiting
-
TransMedicsActive, not recruiting
Clinical Trials on Heart transplant
-
University of FloridaNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...Completed
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruiting
-
University of Southern CaliforniaActive, not recruiting
-
Rocket Pharmaceuticals Inc.Completed
-
EusaPharma (UK) LimitedSyneos HealthTerminatedRespiratory Tract Infections | Pneumonia | Lung Diseases | Acute Respiratory Distress Syndrome | Respiratory Tract DiseaseUnited States
-
Oslo University HospitalSouth-Eastern Norway Regional Health Authority; Norwegian Health AssociationCompletedHeart Transplant Recipients | Physical FitnessSweden, Denmark, Norway
-
Medical University of GdanskRecruitingCovid19 | Postoperative Delirium | Adult Cardiac SurgeryPoland
-
Instituto de Cardiologia do Rio Grande do SulUnknownAcute Myocardial Infarction
-
Boston Medical CenterBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; Massachusetts...TerminatedCrohn's DiseaseUnited States
-
Misook L. ChungCompletedDepression | Heart Failure | Stress | Anxiety | Caregiver BurdenUnited States